ADAL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.106200E-01
Normal-vs-Stage2
3.032600E-01
Normal-vs-Stage3
2.692000E-01
Normal-vs-Stage4
8.941000E-01
Stage1-vs-Stage2
7.361900E-02
Stage1-vs-Stage3
7.821900E-02
Stage1-vs-Stage4
3.011600E-01
Stage2-vs-Stage3
5.427000E-01
Stage2-vs-Stage4
3.396800E-01
Stage3-vs-Stage4
3.039600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.144400E-01
Normal-vs-AfricanAmerican
7.261800E-02
Normal-vs-Asian
1.767810E-01
Caucasian-vs-AfricanAmerican
5.817500E-02
Caucasian-vs-Asian
2.774100E-02
AfricanAmerican-vs-Asian
8.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.553200E-01
Normal-vs-Female
6.905800E-01
Male-vs-Female
3.175600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.324800E-01
Normal-vs-Age(41-60Yrs)
5.190400E-01
Normal-vs-Age(61-80Yrs)
3.770800E-01
Normal-vs-Age(81-100Yrs)
4.030200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.109800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.665400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.707500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.348200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.507600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.465400E-01
Normal-vs-Daily Drinker
2.435400E-01
Normal-vs-Weekly Drinker
3.785400E-01
Normal-vs-Occasional Drinker
4.784400E-01
Normal-vs-Social Drinker
9.307800E-01
Non Drinker-vs-Daily Drinker
6.881400E-01
Non Drinker-vs-Weekly Drinker
5.626200E-01
Non Drinker-vs-Occasional Drinker
8.734000E-01
Non Drinker-vs-Social Drinker
2.521700E-02
Daily Drinker-vs-Weekly Drinker
7.867600E-01
Daily Drinker-vs-Occasional Drinker
9.063200E-01
Daily Drinker-vs-Social Drinker
4.466200E-02
Weekly Drinker-vs-Occasional Drinker
7.843600E-01
Weekly Drinker-vs-Social Drinker
1.378580E-01
Occasional Drinker-vs-Social Drinker
1.392820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.974800E-01
Normal-vs-Grade 2
7.478800E-01
Normal-vs-Grade 3
7.564400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.220600E-01
Grade 1-vs-Grade 3
5.884400E-01
Grade 1-vs-Grade 4
4.974800E-01
Grade 2-vs-Grade 3
8.756400E-01
Grade 2-vs-Grade 4
7.478800E-01
Grade 3-vs-Grade 4
7.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.923180E-01
Normal-vs-NonDiabetic
4.474600E-01
Diabetic-vs-NonDiabetic
3.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.505000E-01
Normal-vs-NoPancreatitis
3.918800E-01
Pancreatitis-vs-NoPancreatitis
3.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.578000E-01
Normal-vs-N1
3.060200E-01
N0-vs-N1
2.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.038600E-01
Normal-vs-TP53-NonMutant
7.869400E-01
TP53-Mutant-vs-TP53-NonMutant
1.951590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
